CARE FAKEEH

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

4017StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	8.58B	7.84B	15.41B	—	—
Market Cap Growth	-9.2%	-49.1%	—	—	—
Enterprise Value	9.85B	8.92B	16.09B	—	—
Last Close Price	37.30	34.10	66.51	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	28.21	22.08	42.58	—	—
PE Ratio	33.46	27.03	53.59	—	—
PEG Ratio	2.33	1.49	2.08	—	—
PS Ratio	2.76	2.54	5.52	—	—
PB Ratio	2.37	2.19	4.64	—	—
P/TBV Ratio	3.22	2.99	6.42	—	—
P/OCF Ratio	23.01	17.28	35.34	—	—
EV/Sales Ratio	3.16	2.89	5.76	—	—
EV/EBITDA Ratio	21.28	21.05	34.93	—	—
EV/EBIT Ratio	35.74	28.95	44.80	—	—
Leverage & Capital
Debt / Equity Ratio	0.35	0.33	0.33	1.80	1.04
Debt / EBITDA Ratio	2.76	2.42	2.08	4.72	4.58
Debt / FCF Ratio	23.12	—	—	70.07	—
Net Debt / Equity Ratio	0.24	0.21	0.16	1.63	0.90
Net Debt / EBITDA Ratio	2.15	1.74	1.18	4.78	4.28
Net Debt / FCF Ratio	15.48	-97.08	-6.67	63.44	-13.98
Efficiency & Liquidity
Asset Turnover	0.55	0.55	0.58	0.50	0.47
Inventory Turnover	12.30	12.73	12.24	11.61	11.26
Quick Ratio	1.32	1.33	1.69	1.04	0.94
Current Ratio	1.65	1.63	1.97	1.30	1.19
Returns & Yields
Return on Equity (ROE)	+5.9%	+7.2%	+11.5%	+13.6%	+17.0%
Return on Assets (ROA)	+3.0%	+3.5%	+4.7%	+4.5%	+5.6%
Return on Invested Capital (ROIC)	+5.4%	+6.7%	+9.2%	+8.2%	+10.6%
Return on Capital Employed (ROCE)	+5.7%	+6.5%	+8.2%	+10.5%	+9.8%
Earnings Yield	+3.0%	+3.7%	+1.9%	—	—
FCF Yield	+0.6%	-0.1%	-0.5%	—	—
Dividend Yield	+0.9%	+1.0%	+0.5%	—	—
Payout Ratio	+26.9%	+23.8%	—	+411.3%	+10.7%
Buyback Yield / Dilution	-2.4%	-5.9%	-8.6%	—	-100.0%
Total Shareholder Return	-1.5%	-4.9%	-8.1%	—	-100.0%

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	8.58B	7.84B	15.41B	—	—
Market Cap Growth	-9.2%	-49.1%	—	—	—
Enterprise Value	9.85B	8.92B	16.09B	—	—
Last Close Price	37.30	34.10	66.51	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	28.21	22.08	42.58	—	—
PE Ratio	33.46	27.03	53.59	—	—
PEG Ratio	2.33	1.49	2.08	—	—
PS Ratio	2.76	2.54	5.52	—	—
PB Ratio	2.37	2.19	4.64	—	—
P/TBV Ratio	3.22	2.99	6.42	—	—
P/OCF Ratio	23.01	17.28	35.34	—	—
EV/Sales Ratio	3.16	2.89	5.76	—	—
EV/EBITDA Ratio	21.28	21.05	34.93	—	—
EV/EBIT Ratio	35.74	28.95	44.80	—	—
Leverage & Capital
Debt / Equity Ratio	0.35	0.33	0.33	1.80	1.04
Debt / EBITDA Ratio	2.76	2.42	2.08	4.72	4.58
Debt / FCF Ratio	23.12	—	—	70.07	—
Net Debt / Equity Ratio	0.24	0.21	0.16	1.63	0.90
Net Debt / EBITDA Ratio	2.15	1.74	1.18	4.78	4.28
Net Debt / FCF Ratio	15.48	-97.08	-6.67	63.44	-13.98
Efficiency & Liquidity
Asset Turnover	0.55	0.55	0.58	0.50	0.47
Inventory Turnover	12.30	12.73	12.24	11.61	11.26
Quick Ratio	1.32	1.33	1.69	1.04	0.94
Current Ratio	1.65	1.63	1.97	1.30	1.19
Returns & Yields
Return on Equity (ROE)	+5.9%	+7.2%	+11.5%	+13.6%	+17.0%
Return on Assets (ROA)	+3.0%	+3.5%	+4.7%	+4.5%	+5.6%
Return on Invested Capital (ROIC)	+5.4%	+6.7%	+9.2%	+8.2%	+10.6%
Return on Capital Employed (ROCE)	+5.7%	+6.5%	+8.2%	+10.5%	+9.8%
Earnings Yield	+3.0%	+3.7%	+1.9%	—	—
FCF Yield	+0.6%	-0.1%	-0.5%	—	—
Dividend Yield	+0.9%	+1.0%	+0.5%	—	—
Payout Ratio	+26.9%	+23.8%	—	+411.3%	+10.7%
Buyback Yield / Dilution	-2.4%	-5.9%	-8.6%	—	-100.0%
Total Shareholder Return	-1.5%	-4.9%	-8.1%	—	-100.0%